What other stocks do shareholders of Proteomics International Laboratories own?

Proteomics International Laboratories (PIQ) Stock Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Free PIQ Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 126,546 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Proteomics International Laboratories alerts:

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About Proteomics International Laboratories

Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. The company was founded in 2001 and is based in Perth, Australia.

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

PIQ Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive PIQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Proteomics International Laboratories and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: ASX:PIQ
CUSIP: N/A
CIK: N/A
Web: www.proteomics.com.au
Phone: 61 8 9389 1992
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): A($0.05)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-5,900,000.00
Net Margins: -194.61%
Pretax Margin: N/A
Return on Equity: -97.26%
Return on Assets: -49.23%

Debt

Debt-to-Equity Ratio: 0.89
Current Ratio: 4.34
Quick Ratio: 2.51

Sales & Book Value

Annual Sales: $3.03 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 13.15
Book Value: A$0.04 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 130,890,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 0.59

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Dr. Richard John Lipscombe M.A.
MA (Oxford), Ph.D., Ph.D., (London), Co-Founder, MD & Director
Ms. Jacqueline Gray
Chief Financial Officer
Mr. John Chuck Morrison
Head of Business Development
Dr. Scott Bringans
Head of Research
Dr. Pearl Tan
Head of Logistics
Mr. Vikesh Malik
Chief Commercialisation Officer
Dr. Kirsten Peters
Head of Clinical Studies
Ms. Karen Teresa Logan ACIS
B.Com., BCom, DipAppCorpGov, F Fin, FCIS, FC, Company Secretary

Key Competitors

View All Competitors

Insiders

Richard Lipscombe
Sold 2,631,579 shares
Total: $2.00 M ($0.76/share)

PIQ Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Proteomics International Laboratories own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Proteomics International Laboratories investors own include Woolworths Group (WOW), Patrys (PAB), Insurance Australia Group (IAG) and Bendigo and Adelaide Bank (BEN).

This page (ASX:PIQ) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial